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We use auditory verbal hallucinations (AVH) to illustrate the challenges in defining and
assessing target engagement in the context of transcranial direct current stimulation
(tDCS) for psychiatric disorders. We defined the target network as the cluster of regions
of interest (ROIs) that are consistently implicated in AVH based on the conjunction of
multimodal meta-analytic neuroimaging data. These were prescribed in the New York
Head (a population derived model) and head models of four single individuals. We
appraised two potential measures of target engagement, tDCS-induced peak electric
field strength and tDCS-modulated volume defined as the percentage of the volume
of the AVH network exposed to electric field magnitude stronger than the postulated
threshold for neuronal excitability. We examined a left unilateral (LUL) montage targeting
the prefrontal cortex (PFC) and temporoparietal junction (TPJ), a bilateral (BL) prefrontal
montage, and a 2 × 1 montage targeting the left PFC and the TPJ bilaterally. Using
computational modeling, we estimated the peak electric field strength and modulated
volume induced by each montage for current amplitudes ranging 1–4 mA. We found
that the LUL montage was inferior to both other montages in terms of peak electric field
strength in right-sided AVH-ROIs. The BL montage was inferior to both other montages
in terms of modulated volume of the left-sided AVH-ROIs. As the modulated volume is
non-linear, its variability between montages reduced for current amplitudes above 3 mA.
These findings illustrate how computational target engagement for tDCS can be tailored
to specific networks and provide a principled approach for future study design.
Keywords: auditory hallucinations, neuroimaging, computational modeling, transcranial direct current stimulation,
schizophrenia

INTRODUCTION
Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique
currently under evaluation for the treatment of neuropsychiatric conditions. tDCS involves the
application of a weak electric current that flows through the brain from anodal to cathodal scalp
electrodes. Proposed mechanisms of action for tDCS involve polarity-dependent changes in the
resting membrane potential (depolarization at the anode and hyperpolarization at the cathode) and
changes in synaptic plasticity (1–5).
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As the application of tDCS to neuropsychiatric disorders
is expanding, the field has begun to recognize significant conceptual gaps that hamper the design and evaluation of tDCS
treatment protocols. In particular, there are currently no assays
for assessing target engagement in tDCS studies, which makes it
very difficult to discern the basis for therapeutic efficacy or lack
thereof. This contrasts with drug development, where measures
of target engagement are an essential and integral part of study
design. In human studies, the in vivo assessment of drugs is critically dependent on proximal markers (e.g., receptor occupancy)
as these enable a direct correlation between target engagement
and measurements of drug efficacy or toxicity (6). In tDCS,
target engagement depends on patient-specific factors related to
head anatomy and functional state and on operator-controlled
factors related to stimulation parameters (montage, current
amplitude) and administration protocol (frequency and duration
of treatment sessions) (7). In psychiatry, an additional challenge
involves uncertainties in the definition of the target brain regions
as a direct and consistent correspondence between symptoms and
brain networks has yet to be established (8).
Here, we present an approach for the assessment of target
engagement measures in tDCS studies of psychiatric symptoms.
We focus on auditory verbal hallucinations (AVH) in patients with
schizophrenia because the neural correlates of AVH are arguably
better defined than those of other psychiatric symptoms. Current
models of AVH propose a dual pathology involving reduced
cognitive control due to hypofunction of prefrontal cortex
(PFC) and abnormal activation of speech-related regions, in the
superior temporal gyrus and temporoparietal junction (TPJ)
(9, 10). This model has informed the tDCS montages that have been
used to treat AVH that conventionally target these two regions.
Despite initial positive results in case series and open label trials
(Table S1 in Supplementary Material), randomized, double-blind,
sham-controlled clinical trials (RCTs) have not been consistently
differentiated between the active tDCS and the sham condition
(11–15). Without methods to assess tDCS target engagement, it is
difficult to interpret these results and improve study design.
In response, we outline an approach for improving the definition of the target network for AVH and for the assessment of two
measures that could putatively provide a quantitative assessment
of target engagement in tDCS. First, we identified the brain
regions that comprise the AVH network using data from metaanalyses of the relevant structural and functional imaging studies.
Second, to accommodate concerns about anatomical variation,
we prescribed the brain regions in the AVH network as regions
of interest (ROIs) in a population-based standardized volume
conductor head model and in four-head models from single
individuals. We then used computational modeling to quantify
two putative measures of target engagement, peak electric field
strength, and percentage-modulated volume derived from three
different tDCS protocols. Peak electric field strength in AVHnetwork regions was chosen as it tracks cortical excitability in
tDCS studies of motor regions (16, 17). We introduced modulated volume as another potential index of target engagement.
As AVH involve a network of brain regions (as opposed to a single
region like the motor cortex), the efficacy of tDCS may depend
on the percentage of the volume of the network being modulated.
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Our primary aim was to quantify the degree of engagement of
the AVH network by different tDCS montages based on the peak
electric field strength and percentage-modulated brain volume.
Our secondary aim was to evaluate the degree of variation in
these as a function of the anatomical variability of the head models used. For modulated volume, which is a non-linear measure,
we also examined interindividual variability for each montage as
a function of increasing current amplitude within the tolerable
current range of 1–4 mA (18). Taken together, these steps outline
a novel approach to the design of tDCS interventions for target
identification and engagement that is image-guided, multi-target,
and supports rational testing of therapeutic hypotheses.

MATERIALS AND METHODS
Identification of the AVH Network
in the Brain

We interrogated databases available through the National Center
for Biotechnology using relevant expanded subject headings and
free text searches to identify meta-analyses of structural and
functional neuroimaging studies of AVH published by February
1, 2017. Coordinates of AVH correlates reported in Talairach
space were transformed to Montreal Neurological Institute
space, using the “tal2icbm_fsl” transform.1 All coordinates were
mapped to the Automated Anatomical Labeling digital atlas (19)
to identify anatomical regions of cross-modal convergence. The
regions thus identified comprise the target regions of interest
(AVH-ROIs) used in subsequent computational models.

Prescription of AVH-ROIs in PopulationLevel and Individual Head Models

Based on the meta-analytic evidence described earlier, we prescribed the AVH-ROIs identified in five previously developed
three-dimensional (3D) realistic models of the human head
(20–22). These comprised the New York Head (S1) and four head
models belonging to single individuals (S2–S5). The New York
Head (S1) is a publicly available standardized volume conductor
head model (0.5 mm3 isotropic resolution) that was constructed
using T1-weighted MRI scans of 152 adult human brains
acquired at 0.5 mm3 isotropic resolution and segmented into 6
tissue compartments comprising the skin, skull, cerebrospinal
fluid (CSF), gray matter, white matter, and air cavities (20). The
individual head models belonged to three men (S2, S3, and S4;
aged 34–41 years) (21–23) and one woman (S5; aged 34 years)
(22). They were generated from structural T1-weighted MRI scan
with 1 mm3 isotropic resolution and segmented into the same
six tissue compartments as the New York Head. These models
are available upon request. For S2, individual tissue probability
maps corresponding to gray matter, white matter, and CSF were
automatically created using FAST (FMRIB Analysis Group,
Oxford, UK) (24). The non-brain regions were semiautomatically
segmented into three tissue compartments including skin, skull,
and air using an in-house segmentation algorithm (21, 25–27),

1
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http://www.brainmap.org/icbm2tal/.
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the volume where E/Eth ≥ 1 (21, 34). We acknowledge that the
modulation threshold in living humans is yet to be conclusively
determined. For these analyses, we used a published estimate
of the modulation threshold (Eth = 0.2 V/m) based on previous
evidence regarding the minimum electric field strength likely
to change the firing rate of neurons in model in vitro systems
(35). Several studies have tried to define the minimum applied
electric field sufficient to modulate transmembrane potential
using different methodologies involving in vitro recordings from
single neurons and brain slices and in vivo recordings in animals
(36–38); the values reported in the case of direct current stimulation ranged from 0.18 to 0.5 V/m, with 0.2 V/m being most
commonly reported. We therefore chose this threshold which
theoretically should yield the maximum modulated brain volume for each montage. Subsequently, interindividual variation in
peak electric field strength and modulated brain volume across
the five head models were determined using coefficient of variation (CV). To examine the effect on the modulated brain volume
of altering the current amplitude, the electric field simulations
for all montages were scaled linearly to span the range of 1–4 mA
and the volume where E/Eth ≥ 1 was estimated for these ranges.
Finally, we used analyses of variance, followed by Bonferronicorrected post hoc pairwise comparisons, to determine if the
peak electric field strength and modulated brain volume in the
AVH-ROIs differed across the three tDCS montages. The effect
size for the peak electric field strength and modulated brain
volume between each pair of electrode montages was computed
using the Cohen’s d (39).

followed by correction of segmentation errors using tools from
ITK-SNAP (28). For S3–S5, automated segmentation was performed using SPM (29), followed by correction of segmentation
errors using an in-house MATLAB script (30) and ScanIP tools
(Simpleware Ltd., Exeter, UK).

tDCS Electrode Montages

The search space for optimal electrode placement in the treatment
of AVH is too vast for systematic empirical evaluation. Taking a
pragmatic approach, we focused on three montages: (A) a left
unilateral (LUL) montage with anode over the left PFC (F3-FP1)
and cathode over the left TPJ (P3), (B) a bilateral (BL) prefrontal
1 × 1 montage with the anode over the left PFC (F3-FP1) and
cathode over the right PFC (FP2), and (C) a third montage (2 × 1)
with one anode over the left dorsolateral PFC (F3-FP1) and two
cathodes, one on the left and the other on the right TPJ (T3-P3
and T4-P4). The first two montages have been most widely used
in tDCS studies (Tables S1 and S2 in Supplementary Material),
while the third was included because of its theoretical potential to
provide better target engagement of right-sided target AVH-ROIs.

Electric Field Computational Modeling

Computational modeling was performed separately for each of
the three montages in each of the five head models. In addition,
we assessed the effect of varying current amplitude across all three
montages and head models within the range of 1–4 mA, which is
known to be tolerable in humans (31). We used the same computational modeling approach based on our previous work (21, 26).
The tDCS sponge electrodes were modeled with 5 cm × 7 cm
surface intersecting the scalp. For each montage, the complete 3D
head models incorporating the tDCS electrodes were adaptively
tessellated to produce finite element models using the restricted
Delaunay triangulation algorithm (32). The electric conductivities
used for each tissue type across all five head models were as follows:
gray matter = 0.33 S/m, white matter = 0.14 S/m, CSF = 1.79 S/m,
skin = 0.43 S/m, skull = 0.0132 S/m, and air = 0 S/m (21, 23, 27,
33, 34). The electrodes were assumed to have the conductivity of
saline (1.4 S/m) (22). Constant electric current was applied to
the electrode surfaces away from the head (26). The LUL and BL
montages correspond to those that have been used in the current
literature, and accordingly current intensity was set at 2 mA,
unless otherwise stated (Table S1 in Supplementary Material).
For the 2 × 1 montage, 2 mA was applied to the frontal anode
and −1 mA to each of the posterior cathodes, unless otherwise
stated. The electric field distribution was computed by solving
the Laplace equation using the preconditioned conjugate solver
within ANSYS (ANSYS Inc., Canonsburg, PA, USA) (21, 26).
In addition, we modeled radial cortical electric field that represents the inward and outward component of the electric field
relative to the cortical surface (22).

RESULTS
Identification and Prescription
of the Target Brain Network for AVH

We identified six meta-analyses that examined structural (40, 41)
and functional differences in patients with AVH compared
to healthy individuals (42–45). Details of the primary studies
included in each meta-analysis are provided in Tables S3–S10 in
Supplementary Material. Across all meta-analyses, brain regions
consistently associated with AVH comprised the primary and
secondary auditory cortex located in the superior temporal gyrus
and in the Heschl’s gyrus; Broca’s and Wernicke’s area, respectively,
located in the inferior frontal gyrus (pars opercularis and pars
triangularis) and in the posterior superior temporal gyrus; the
anterior cingulate gyrus; the somatosensory and motor cortices,
respectively, located in the postcentral and precentral gyrus; the
insula; and the hippocampus and the thalamus (Figure 1; Table
S11 in Supplementary Material). Of note, most of the regions
identified were BL (Table S11 in Supplementary Material). Based
on these results, AVH-ROIs were prescribed in each of the five
head models (Figure 1B).

Data Analysis

Effect of Anatomic Variation and Current
Amplitude on Peak Electric Field Strength

We computed the electric field magnitude (E) and the percentage modulated volume for each AVH-ROI. The modulated
brain volume was defined as the percentage of the brain volume
(within the left or right AVH networks) exposed to electric field
magnitude (E) stronger than the modulation threshold (Eth), i.e.,
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Figure 2 shows the simulated LUL, BL, and 2 × 1 tDCS configurations. The spatial distributions of the electric field on the cortical
surface and directional electric field normal to the cortical surface
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Figure 1 | (A) Spatial distribution of the coordinates from meta-analyses of studies of patients with auditory verbal hallucinations (AVH) derived from Table S11 in
Supplementary Material. Red = during AVH, green = during auditory or language tasks, and blue = morphometric studies. (B) Three-dimensional rendering of the
brain regions of interest associated with AVH in a representative model. L, left.

(inward and outward) are plotted for each modality in each
individual. For each montage and each AVH-ROI, we estimated
the mean peak electric field strength across the five head models.
Figures 3A,B present the peak electric field strengths for each
montage averaged across the five head models at the conventional
2 mA current amplitude. Figures 3C,D present the CV of the
peak electric field strength in each AVH-ROI across the five head
models for each montage. The LUL 1 × 1 montage predominantly
induced electric fields in the left hemisphere; the inward current
flow occurred mostly through the left dorsolateral prefrontal
cortex while the outward current flow occurred through the left
temporoparietal and occipital regions. The BL prefrontal 1 × 1
montage generated comparable electric field magnitude in both
hemispheres; the inward and outward flow occurred mostly
over the prefrontal and frontal areas. The 2 × 1 montage induced
electric fields in the left- and in the right-sided AVH-ROIs; the
inward and outflow flow occurred over the frontal cortex and the
temporoparietal regions, respectively.
We found significant differences in peak electric field strength
across the three electrode montages (LUL, BL, and 2 × 1) as
shown in Table 1. Bonferroni-corrected pairwise comparisons
showed the montages induced significantly different electric
field strengths in several right-sided AVH-ROIs. Specifically,
the BL montage generated higher peak electric field strengths
in the right inferior frontal gyrus and insula than the other
two montages (p < 0.001). The 2 × 1 montage produced higher
peak electric field in the right postcentral gyrus than the others
(p < 0.05).

Frontiers in Psychiatry | www.frontiersin.org

Effect of Anatomic Variation and Current
Amplitude on Percentage Modulated
Brain Volume

Figure 4 shows the electric field maps relative to the threshold
electric field (E/Eth) for current amplitudes in the range of
1–4 mA for each montage. For each montage and each AVH-ROI
in each head model, we estimated the percentage of modulated
volume [i.e., percentage of the AVH network volume in which
the electric field strength (E) was above 0.2 V/m]. We used the
threshold 0.2 V/m as it is the postulated threshold for neuronal
excitability (35). Figures 5A,B show the percentage modulated
volume (E ≥ Eth) for each of the three montages for the left- and
right-sided AVH-ROIs for current amplitudes ranging from 1
to 4 mA averaged across the five head models. Figures 5C,D
show the corresponding CV in the left- and right-sided AVHROIs for each montage for current amplitudes ranging from 1 to
4 mA. The corresponding data for each AVH-ROI are shown in
Figures S1–S4 in Supplementary Material. Increasing the current
amplitude increased modulated volumes and reduced interindividual variability, particularly for the LUL and 2 × 1 montages
(Figures 4 and 5). Variability between montages reduced in
general for current amplitudes above 3 mA. Nevertheless, we
found significant differences in modulated volume across the
three electrode montages (LUL, BL, and 2 × 1) as shown in
Table 2. The modulated brain volume in the left-side AVH-ROIs
was significantly different across the montages for the range of
2–4 mA at which lower modulated brain volume was produced

4
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Figure 2 | Electric field modeling of transcranial direct current stimulation (tDCS) for three montages: (A) left unilateral 1 × 1 montage with F3-FP1 as the anode
and T3-P3 as the cathode, (B) bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as the cathode, and (C) 2 × 1 montage with F3-FP1 as the
anode and cathodes at T3-P3 and T4-P4. First column shows tDCS electrode placements representing anode (red) and cathode (blue) electrodes in the New York
head model (Subject 1; S1). Rows from top to bottom show electric field magnitude (E) and electric field normal to the cortical surface (En) for the models of
Subjects 1–5 (S1–S5) at current amplitude of 2 mA.

by the BL compared to the other two montages (p < 0.05). In
contrast, the BL generated statistically higher modulated volume
in the right-side AVH-ROIs than the other two montages at low
current of 1 mA (p < 0.001).

Table S11 in Supplementary Material) and from individual
studies point to additional involvement of right-sided brain
regions to the pathophysiology of AVH (47–51). Second, there
is inter-individual variability in brain structure and function
in general (52) and in the AVH-related network in particular
(50, 51). Individual differences in the spatial distribution of
tDCS-induced electric fields may impact on the engagement of
AVH-related regions and hence clinical response. Third, there is
no behavioral, cognitive or neurophysiological measure that can
be used to assess AVH-related neural changes during or following
a single tDCS session, in contrast to electroconvulsive therapy
(53) and repetitive transcranial magnetic stimulation (54) where
seizure and motor excitability threshold can be, respectively, used
as a threshold for titrating treatment.
In response to these uncertainties, we tested whether computational modeling of electric field measures induced by tDCS
can be meaningfully used to assess the engagement of the AVH

DISCUSSION
Here, we use AVH to illustrate the challenges in defining and
assessing target engagement in the context of tDCS for psychiatric disorders and to propose a strategy for the evaluation of tDCS
protocols.
There are three main challenges. First, AVH arise from dysfunction in a brain network (Figure 1) rather than a single brain
region which leads to uncertainty about which regions within
the AVH-related network may constitute ideal targets for tDCS
(46). Moreover, commonly used montages often target left-sided
AVH-ROIs while evidence from the meta-analyses (Figure 1;

Frontiers in Psychiatry | www.frontiersin.org
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Figure 3 | (A) Regional electric field strength and spatial distribution at a current of 2 mA generated by each transcranial direct current stimulation montage in a
representative head model. (B) Peak electric field magnitude at a current of 2 mA in each auditory verbal hallucinations (AVH) region of interest (ROI). Bars show
mean values, and error bars show SD across the five head models for each target AVH-ROI. (C) Spatial distribution of the coefficient of variation (CV) of peak electric
field magnitude in each target AVH-ROI across the five head models for each montage. (D) CV of the peak electric field magnitude in target AVH-ROI across the five
head models for each montage. LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3 as the cathode; BL, bilateral prefrontal 1 × 1 montage with
F3-FP1 as the anode and FP2 as the cathode; 2 × 1, montage with one anode at F3-FP1 and cathodes at T3-P3 and T4-P4. IFGo, inferior frontal gyrus (pars
opercularis); IFGt, inferior frontal gyrus (pars triangularis); ACG, anterior cingulate gyrus; PreCG, precentral gyrus; PoCG, postcentral gyrus; HES, Heschl’s gyrus;
STG, superior temporal gyrus; HIP, hippocampus; INS, insula; THA, thalamus.

Frontiers in Psychiatry | www.frontiersin.org
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Table 1 | Differences in peak electric field strength for each region of interest in the auditory verbal hallucinations network across electrode montages.
Laterality

L
L
L
L
L
L
L
L
L
L
R
R
R
R
R
R
R

Region

Inferior frontal gyrus, pars opercularis
Inferior frontal gyrus, pars triangularis
Anterior cingulate gyrus
Precentral gyrus
Postcentral gyrus
Heschl’s gyrus
Superior temporal gyrus
Hippocampus
Insula
Thalamus
Inferior frontal gyrus, pars opercularis
Inferior frontal gyrus, pars triangularis
Postcentral gyrus
Heschl’s gyrus
Superior temporal gyrus
Insula
Thalamus

Analysis of variance
F (p-value)

1.55 (0.25)
3.89 (0.051)
5.30 (0.02)
0.85 (0.44)
0.27 (0.76)
6.64 (0.01)
1.07 (0.37)
2.97 (0.08)
1.39 (0.28)
2.16 (0.15)
52.62 (1.14e−6)
26.11 (4.25e−5)
12.48 (0.001)
6.46 (0.01)
5.67 (0.01)
24.3 (6.03e−5)
0.79 (0.47)

Post hoc pairwise comparisons

NS
NS
BL > LUL*
NS
NS
LUL > BL*
NS
NS
NS
NS
BL > LUL***; BL > 2 × 1***
BL > LUL***; BL > 2 × 1***
2 × 1 > LUL*; 2 × 1 > BL***
BL > LUL*
2 × 1 > LUL*
BL > LUL***; BL > 2 × 1***
NS

Absolute effect size (Cohen’s d)
LUL vs BL

LUL vs
2×1

BL vs
2×1

1.19
1.84
2.08
0.82
0.45
2.29
0.86
0.83
0.81
0.80
5.99
3.89
0.96
2.30
0.67
4.48
0.70

0.03
0.36
0.57
0.34
0.09
0.65
0.66
0.63
0.17
0.63
1.47
1.10
2.24
1.29
1.75
0.84
0.07

0.88
1.17
1.47
0.47
0.33
2.03
0.34
1.90
1.14
1.25
4.70
3.13
2.99
0.91
1.60
3.31
0.83

Only results that survive Bonferroni correction for multiple comparisons are reported as significant; NS, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001; LUL, left unilateral
montage with anode over F3-FP1 and cathode over the left P3; BL, bilateral prefrontal montage with the anode over F3-FP1 and cathode over FP2; 2 × 1, one anode over the
F3-FP1 and two cathodes, one over T3-P3 and the other over T4-P4; electrode placements are based on the International 10–20 system.

Figure 4 | Brain regions with electric field strength above the modulation threshold (0.2 V/m) in a representative model as a function of current amplitude. Spatial
distribution of the electric field shown for the cortical surface and in a representative coronal slice for current amplitudes ranging from 1 to 4 mA for each montage.
LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3 as the cathode; BL, bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as
the cathode; 2 × 1, montage with one anode at F3-FP1 and cathodes at T3-P3 and T4-P4. R, right.

network. We mined the available neuroimaging literature to
define target ROIs implicated in AVH (Figure 1) and used computational modeling approach to assess the engagement of these
ROIs in five head models using the three different tDCS montages
(Figure 2). The search space for optimal electrode placement in
the treatment of AVH is too vast for empirical evaluation of brute

Frontiers in Psychiatry | www.frontiersin.org

force. Taking a pragmatic approach, we considered the LUL and
BL prefrontal montages as these are most commonly used in the
literature (Tables S1 and S2 in Supplementary Material). We also
evaluated an experimental 2 × 1 montage, because of its theoretical potential to provide better target engagement of right-sided
target AVH-ROIs. We used two measures of target engagement,
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Figure 5 | Percentage modulated volume in (A) left-sided and (B) right-sided auditory verbal hallucinations (AVH) regions of interest (ROIs) across all head
models for each of the three montages as a function of current amplitude. Coefficient of variation in percentage-modulated volume in (C) left-sided and
(D) right-sided AVH-ROIs across all head models for each of the three montages. LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3
as the cathode; BL, bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as the cathode; 2 × 1, montage with one anode at F3-FP1 and
cathodes at T3-P3 and T4-P4.

specifically peak electric field magnitude in each AVH-ROI and
modulated brain volume of the AVH-network.
In terms of peak electrical field strength, the three montages
differed only in a few right-sided AVH-ROIs. Specifically, the
BL montage generated higher peak electric field strengths in the
right inferior frontal gyrus and insula, while the 2 × 1 montage
produced higher peak electric field in the right postcentral gyrus.
Both of these regions have been associated with increased AVH
frequency in patients who experience persistent AVH (44). The
strength of the tDCS-induced electric field is a conventional
measure of assessing the spatial distribution of the electric fields
generated by different electrode configurations. However, its
functional significance in terms of clinical efficacy has not been
tested and is currently unknown. If we assume that peak electric
field strength is associated with clinical efficacy, the current
results suggest that the commonly used LUL montage is perhaps
the least advantageous if one is interested in electrode montages
that have the potential to modulate right-sided AVH-ROIs.
The three montages also differed in terms of modulated
volume. In this case, however, differences were noted for the
left-sided AVH network where both the LUL and 2 × 1 montages
produced higher modulated volumes than the BL for currents

Frontiers in Psychiatry | www.frontiersin.org

ranging from 2 to 4 mA. As expected, the BL montage produced
the highest focality within frontal regions due to the proximity
of the electrodes (21). Consistent with previous findings (21),
increasing the current amplitude increased modulated volume
within AVH network. For the threshold-based modulated volume measure, variability between montages reduced in general
for current amplitudes above 3 mA. Reduced interindividual
variation at higher currents resulted from increased modulated
volume within AVH network across multiple realistic head models. This is important for clinical applications, since it implies that
increasing the current amplitude may be one possible option to
overcoming anatomical variability and uncertainty about optimal
electrode placement and potentially improve the efficacy of tDCS
for AVH.
This study provides a computational evidence for two different measures of target engagement that behave differently across
different montages. There are other parameters in tDCS protocols
involving duration of tDCS session, interval of administration,
and length of trial (55) that may contribute to efficacy but could
not be examined here. We did not address the issue of tolerability
for higher current amplitudes although the excellent tolerability
of tDCS allows optimism (18, 31, 56). Nevertheless, we have
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Table 2 | Differences in modulated brain volume for current amplitudes in the range of 1–4 mA for the left- and right-sided regions of interest (ROIs) in the auditory
verbal hallucinations network across electrode montages.
Current (mA)

Analysis of variance
F (p-value)

Post hoc pairwise comparisons

Absolute effect size (Cohen’s d)
LUL vs BL

LUL vs 2 × 1

BL vs 2 × 1

Left auditory verbal hallucinations (AVH)-ROIs
1
0.76 (0.49)
1.5
3.32 (0.07)
2
11.95 (0.001)
2.5
21.01 (0.0001)
3
18.57 (0.0002)
3.5
9 (0.004)
4
5.92 (0.01)

NS
NS
LUL > BL**; 2 × 1 > BL**
LUL > BL***; 2 × 1 > BL***
LUL > BL**; 2 × 1 > BL***
LUL > BL*; 2 × 1 > BL**
LUL > BL*; 2 × 1 > BL*

0.67
1.82
3.07
3.25
2.75
1.88
1.53

0.47
0.31
0.05
0.22
0.24
0.27
0.20

0.32
1.33
2.91
3.84
3.07
1.97
1.56

Right AVH-ROIs
1
1.5
2
2.5
3
3.5
4

BL > LUL***; BL > 2 × 1***
BL > LUL*
NS
NS
NS
NS
NS

4.19
2.08
1.40
0.81
0.58
0.58
0.53

1.58
1.06
0.93
1.12
0.97
1.20
1.14

2.97
1.10
0.12
0.66
0.66
0.92
0.90

28.76 (2.6e−5)
5.63 (0.01)
2.01 (0.17)
2.16 (0.15)
1.58 (0.24)
2.17 (0.15)
1.88 (0.19)

Only results that survive Bonferroni correction for multiple comparisons are reported as significant; NS, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001; LUL, left unilateral
montage with anode over F3-FP1 and cathode over the left P3; BL, bilateral prefrontal montage with the anode over F3-FP1 and cathode over FP2; 2 × 1, one anode over the
F3-FP1 and two cathodes, one over T3-P3 and the other over T4-P4; electrode placements are based on the International 10–20 system.

provided a road map for the development of target engagement
measures for tDCS that is based on neuroimaging evidence
regarding the target networks and accommodates uncertainty
about patient-specific abnormalities. This translational approach
not only combines advances in computational modeling with
knowledge gained from behavioral and functional neuroimaging
studies regarding target definition and target engagement but
also highlights knowledge gaps and points to avenues for future
research.
Generally, the principled computational approach developed
here could inform target engagement across tDCS application.
Prior computational models typically considered electric field
magnitude (or normal direction) in a single ROI. We show that
consideration of multiple nodes in a functional network (based
on imaging and trial meta-analysis) forces decisions on region
stimulation and sparring that then suggest divergent optimal
montages. The approach outlined here is particularly relevant for
study designs that adopt the Research Domain Criteria (RDoC)
framework.2 The RDoC initiative specifies neural circuits that
may be theoretically and empirically linked to clinical symptoms
and cognitive constructs. This framework therefore can be used
to aid in the specification of target networks in future tDCS studies in neuropsychiatry. Moreover, considering a simple linear
electric field (magnitude or normal) vs non-linear measures of
ROI influence (such as our threshold-based volume measures)
leads to different conclusion on the value of current intensity and
best montage. As such, tDCS interventions rationalized based on
computational modeling should be explicit about the underlying
assumptions regarding network (dys)function and side effects
(i.e., selection of target and avoid ROIs), biophysics of stimula2

tion (i.e., measure of ROI engagement), and goals (e.g., reduce
interindividual variation).
Our approach also addresses issues relevant to personalized
psychiatry because, as we have shown, individual variations in
electrical field distribution in tDCS can be overcome by protocol
modifications such as increasing the current amplitude to 4 mA.
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